Core Lab (CLB) Q3 2026 earnings review
Core Lab's international labs rebound, but new attacks stall growth
Core Lab, which tests oilfield rock and fluids and sells well-completion tools, rebounded in its international labs while its completion profit fell short. Third-quarter revenue rose 6% from last quarter to $132 million, and profit per share excluding one-offs climbed to $0.16 as Reservoir Description beat its profit plan. However, chief executive Larry Bruno's fourth-quarter outlook keeps total revenue and profit per share roughly flat from the third quarter.
| Revenue | $132.1M +6.0% from last quarter; -1.8% from a year ago |
|---|---|
| Profit per share, excluding one-offs | $0.16 +45% from last quarter; -27% from a year ago |
| Reservoir Description profit, excluding one-offs | $8.1M beat $5.5–7.9M plan |
| Q4 revenue outlook | $128.5–134.5M middle of the range: -0.4% from Q3 |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because new attacks in the Middle East early in the fourth quarter stalled the lab recovery right after it began. Third-quarter lab margins proved that work in Asia-Pacific, Africa and Latin America can lift profit quickly when volume grows, turning 78% of new lab revenue into operating profit. One caution: higher inventory and unpaid customer bills cut free cash flow to $1.7 million, leaving almost nothing to reduce debt.
The question now is whether international projects outside the Middle East can grow fast enough to overcome ongoing conflict delays and US seasonal slowdowns. Either multi-year offshore contracts in Asia-Pacific and South America carry revenue higher in 2027, or repeated Middle East disruptions keep lab utilization and cash flow stuck near current levels. First-quarter 2027 lab revenue and fourth-quarter cash collection will tell.
🐂 Bull Case
International Lab Work Lifted Profit Margins
Reservoir Description, Core Lab's largest business, tests rock and fluid samples from international and offshore oil fields. Because the oilfield laboratory group keeps its testing network and staff in place during downturns, small changes in work volume cause large swings in profit. Chief executive Larry Bruno said international demand improved across Europe-Africa, Asia-Pacific and Latin America, and believed Asia-Pacific indicates "the region is entering a period of sustained activity growth".
Segment revenue rose 7.1% from last quarter to $84.3 million, beating the $81 million to $84 million plan. Operating profit excluding one-offs more than doubled from last quarter to $8.1 million, topping the $5.5 million to $7.9 million forecast. That recovery lowered total cost of services and product sales by 1.8 percentage points of revenue from last quarter, because 78% of the new lab sales turned into profit.
What to watch: Reservoir Description operating profit in the fourth quarter against the $5.1 million to $8.3 million plan. Holding near the top of that range despite Middle East delays would show that non-Middle East lab projects carry enough profit to cover the fixed lab network.
New Completion Tools Lifted US Product Sales
Production Enhancement sells explosives to punch holes in oil wells and chemical tracers to track fluid flow underground. While US onshore drilling has been sluggish, Core Lab wants its patented tools to win market share. Product sales in the division jumped 14% from last quarter, lifting total segment revenue 4.1% from last quarter and 3.2% from a year ago to $47.8 million.
A North American service customer expanded its use of AERO, a system for assembling and aiming well charges, while a Brazilian producer adopted SpectraFlood chemical tracers across more than 50 onshore fields. Because customers are buying more of these tools and delayed offshore service jobs should resume, the company expects segment operating profit to rebound to between $5.5 million and $6.7 million next quarter.
What to watch: fourth-quarter Production Enhancement revenue against the $47.5 million to $49.5 million outlook. Hitting the upper half during the usual year-end slowdown in US land drilling would show that new tool adoption is outrunning the wider US oilfield slowdown.
🐻 Bear Case
New Attacks Cut Short the Middle East Rebound
War in the Middle East and sanctions on Russia have disrupted crude oil shipping and laboratory testing for over a year. Bruno said that "There was a gradual improvement in activity in the Middle East, particularly late in the quarter", as ship traffic through the Strait of Hormuz picked up. Even so, crude oil testing in the region stayed below pre-conflict levels.
That late-quarter recovery did not last. In its outlook, Core Lab warned that "Early in the fourth quarter, attacks affected client operations in the region and have already resulted in some project delays". Because of those attacks, the company's fourth-quarter plan puts Reservoir Description revenue at $81 million to $85 million and segment operating profit at $5.1 million to $8.3 million, down 17% from this quarter at the middle of the range.
What to watch: first-quarter 2027 Reservoir Description revenue outlook on the next earnings call. Another flat or lower quarter would show that Middle East disruptions are offsetting the long-promised international recovery.
Offshore Delays and Tariffs Hurt Completion Margins
Last quarter, Production Enhancement operating profit jumped to $5.3 million excluding one-offs, helped by a one-time refund of import tariffs paid in earlier periods. This quarter tested what the business earns without that help, and while paying more for imported raw materials used to build perforating systems.
Segment operating profit excluding one-offs fell 17.7% from last quarter to $4.4 million, missing the company's $4.8 million to $6.9 million plan. Operating margin in the division dropped from 11.6% to 9.2% as customers in the Gulf of America delayed several large diagnostic service projects out of the third quarter, leaving lower-margin product sales to carry the quarter.
What to watch: fourth-quarter Production Enhancement operating profit against the $5.5 million to $6.7 million plan. Falling short of that range would indicate that higher raw material costs are still squeezing manufacturing margins even when delayed offshore service jobs return.
Working Capital Drained Cash and Stalled Debt Paydown
Core Lab aims to turn profit into free cash flow to pay down debt and buy back shares. This quarter, higher raw material costs "increased the cost of carrying inventory", and a late-quarter pickup in work left more unpaid customer bills at the end of September.
- Free cash flow: $1.7 million, down 73.5% from a year ago and down from $3.1 million last quarter
- Inventories: $60.7 million, up 4.7% from last quarter and up 4.2% from a year ago
- Accounts receivable: $115.6 million, up 6.2% from last quarter
- Net debt: $93.4 million, down $0.2 million from last quarter and up 2.2% from a year ago
Because the company spent $1.1 million buying back 87,873 shares and paid its quarterly dividend, almost no cash was left to reduce debt. What to watch: fourth-quarter free cash flow and inventory levels. If inventories keep rising while sales stay flat, the company will have little cash to pay down its variable-rate debt before 2027 refinancing deadlines approach.
Risks this quarter didn't answer
Two standing concerns from prior quarters could not be checked from the earnings release alone because the detailed figures usually appear in the quarterly filing or on the conference call.
- Global crude oil cargo movement: last quarter the filing showed global tanker traffic down 15% to 20% from a year ago; the release notes gradual improvement late in the quarter but gives no percentage.
- Client exploration dry holes: earlier delays came from oil companies drilling unsuccessful wells on committed projects; the release names new appraisal work in Australia for the "evaluation of this emerging play" but gives no update on overall exploration success rates.
💲 Other KPIs
Return on invested capital — trailing four-quarter operating profit after tax divided by average debt, leases and equity — fell to 5.9% from 8.3% last quarter and 9.7% a year ago. Trailing four-quarter after-tax operating profit dropped to $23.4 million from $32.9 million last quarter as weak first-half results weighed on the rolling total.
Corporate overhead costs rose 2.9% from last quarter and 5.4% from a year ago to $11.3 million. Because sales fell slightly from last year, overhead took 8.5% of revenue, up 0.6 percentage points from a year ago by our math, matching the second-half pace implied by the oilfield group's earlier full-year cost plan.
Spending on lab and manufacturing equipment — excluding $0.5 million of insurance-funded rebuilding at the fire-damaged Aberdeen facility in Scotland — dropped to $3.2 million, or 2.5% of sales, from $4.7 million last quarter. Nine-month operational spending reached $11.4 million, keeping the Houston-based firm on track for its $15 million to $18 million full-year target.
Average diluted shares fell 0.4% from last quarter and 0.8% from a year ago. It bought back 87,873 shares for $1.1 million during the quarter, slowing its buyback pace from 214,712 shares for $2.7 million in the second quarter as free cash flow tightened.
🔮 Guidance
New. The plan calls for revenue to stay roughly flat from this quarter's $132.1 million, down 0.4% at the middle of the range and down 4.9% from a strong fourth quarter last year by our math. Early fourth-quarter attacks in the Middle East and the usual year-end slowdown in US land drilling hold back growth.
New. The forecast puts operating profit at $12.9 million at the middle of the range, up 2.3% from this quarter's $12.6 million excluding one-offs and down 18.0% from a year ago by our math. Operating margin stays near 10% as higher completion service profit offsets a step-down in Middle East lab work.
New. The outlook keeps profit per share excluding foreign exchange at $0.16 at the middle of the range, matching this quarter's $0.16 and down 23.8% from $0.21 a year ago by our math. The projection assumes a 25% tax rate.
New. At the middle of the ranges, the lab segment's sales slip 1.6% from this quarter to $83.0 million (down 10.1% from a year ago by our math) and operating profit drops 17.2% to $6.7 million. Project delays from early fourth-quarter attacks in the Middle East drive the pullback.
New. At the middle of the ranges, completion revenue rises 1.6% from this quarter to $48.5 million (up 5.5% from a year ago by our math) and operating profit jumps 38.8% to $6.1 million. The rebound relies on high-margin offshore diagnostic jobs delayed from the third quarter.
❓ Key Questions
How much did global crude tanker traffic fall this quarter?
Last quarter's filing disclosed a 15% to 20% drop in global crude cargo movement, which drives high-margin oil testing. The release mentions gradual improvement late in the quarter through the Strait of Hormuz, but investors need the exact figure to judge how depressed testing remains.
Have the delayed Gulf of America diagnostic jobs started?
Production Enhancement missed its third-quarter profit plan because several large offshore diagnostic jobs slipped, and the fourth-quarter profit rebound to $5.5 million to $6.7 million depends on them. Management has not said whether those jobs are already underway in October.
How much revenue did early Q4 Middle East attacks delay?
The company said attacks early in the fourth quarter affected client operations and delayed projects, pushing expected Reservoir Description profit down 17% at the middle of the range. Quantifying the delayed work would show how much lab growth other regions are generating underneath.
When will raw material inventories stop draining cash?
Inventories rose 4.7% from last quarter to $60.7 million on higher raw material costs for perforating systems, cutting free cash flow to $1.7 million. With revenue projected to stay flat in the fourth quarter, investors need to know when working capital will release cash.